Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
North Carolina Voter Guide 2024: Who's running, how, where, when to vote in NC election
Recommended
Help North Carolina rebuild: WRAL's Hurricane Helene recovery fund raises $900K+
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
54.93
+0.07 (+0.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi-Aventis S.A. ADR
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Sanofi Invests To Build Internal Capabilities in mRNA
June 29, 2021
Sanofi SA (NASDAQ: SNY) is working towards its R&D approach around mRNA to accelerate the development and delivery of next-generation vaccines. The company will ...
Via
Benzinga
The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
June 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...
Via
Benzinga
Saint Warren
June 28, 2021
Today the WTI oil price rose further up over 1%.
Via
Talk Markets
Sanofi Divests 16 Consumer Health Brands To Stada
June 28, 2021
Amid a reorganization scheme aimed at slashing costs and prioritizing blockbuster immunology Dupixent, Sanofi SA (NASDAQ: SNY) will offload 16 consumer health...
Via
Benzinga
Sanofi's Soliqua Shows Improved Blood Sugar Control Without Weigh Gain Against Premixed Insulin
June 28, 2021
Sanofi SA (NASDAQ: SNY) has announced new study data of Soliqua 100/33 (insulin glargine and lixisenatide injection) that met its two primary endpoints and all key...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
June 28, 2021
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
AstraZeneca's Nirsevimab Shows Favorable Safety, Tolerability Profile In Infants At High Risk Of RSV
June 28, 2021
AstraZeneca Plc (NASDAQ: AZN) announced data from the MEDLEY Phase 2/3 trial evaluating nirsevimab in infants at high risk of respiratory syncytial virus (RSV). The trial...
Via
Benzinga
Sanofi - Regeneron's Immunotherapy Scores European Approval For Skin And Lung Cancer Settings
June 25, 2021
The European Commission (EC) has approved Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Libtayo (cemiplimab) for two...
Via
Benzinga
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs
June 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
14 Biotech Stocks To Watch Over The Next 6 Months
June 23, 2021
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
June 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...
Via
Benzinga
Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial
June 22, 2021
Sanofi Pasteur, vaccine unit of Sanofi SA (NASDAQ: SNY) and Translate Bio Inc (NASDAQ: TBIO) have initiated a Phase 1 trial evaluating an mRNA-based...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
June 21, 2021
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
How This Pharma Company Can Benefit From Its Competitors
June 20, 2021
Delays in FDA approval for Incyte could spell good news for Sanofi.
Via
The Motley Fool
Exposures
Product Safety
Europe Approves Sanofi's Expanded Use Of Aubagio In Pediatric Patients With Multiple Sclerosis
June 18, 2021
The European Commission has approved Sanofi SA's (NASDAQ: SNY) Aubagio (teriflunomide) for the treatment of pediatric patients 10 to 17 years of age with...
Via
Benzinga
BioNTech Starts Dosing In Mid-Stage Melanoma Vaccine Trial
June 18, 2021
BioNTech SE (NASDAQ: BNTX) has dosed the first patient in its Phase 2 trial evaluating the BNT111 cancer vaccine. The study evaluates the therapeutic cancer...
Via
Benzinga
Sanofi Scores FDA Approval For Flu-Shot Facility In US
June 17, 2021
The FDA has approved Sanofi SA's (NASDAQ: SNY) newly completed plant in Swiftwater, Pennsylvania. The license will allow Sanofi to begin production of its...
Via
Benzinga
Exposures
Product Safety
Elanco Is Looking To Challenge Zoetis, Will The $440 Million Kindred Buyout Help?
June 16, 2021
Elanco Animal Health said Wednesday it would buy Kindred Biosciences for roughly $440 million, sending KIN stock soaring.
Via
Investor's Business Daily
Sanofi's Sutimlimab Hits Endpoint Goal In Rare Anemia Study After FDA Rejection
June 11, 2021
Sanofi SA’s (NASDAQ: SNY) sutimlimab nailed all three of its primary endpoints in its Phase 3 CADENZA study for patients with cold agglutinin disease. This...
Via
Benzinga
Exposures
Product Safety
Elevation Oncology Files for $100M IPO
June 07, 2021
Elevation Oncology has filed to raise $100 million in an IPO. See SEC prospectus here. Proceeds will be used to support the development of seribantumab that failed...
Via
Benzinga
Topics
Initial Public Offering
Regulatory Compliance
Exposures
Legal
Regulatory
Securities Market
Sanofi Inks Partnership for Late-Stage Trial of Amcenestrant as Add-On Breast Cancer Therapy
June 04, 2021
Sanofi SA (NASDAQ: SNY) has secured partners for a Phase 3 trial to study amcenestrant versus the hormone therapy tamoxifen in breast cancer. The Breast...
Via
Benzinga
The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact
June 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 3) BioCryst Pharmaceuticals,...
Via
Benzinga
Diversifying to Conquer: Fortress Biotech (FBIO) Partnering Expansion Driving Progress in Cancer Immunotherapy and Rare Disease Therapeutics
June 03, 2021
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or...
Via
Benzinga
P/E Ratio Insights for Sanofi
June 01, 2021
In the current market session, Sanofi Inc. (NASDAQ:SNY) is trading at $52.60, after a 1.55% decrease. However, over the past month, the stock spiked by 4.32%, and in...
Via
Benzinga
Sanofi Stops Venglustat Development In Rare Genetic Kidney Disorder
June 01, 2021
Sanofi SA (NASDAQ: SNY) has halted the clinical program of venglustat in autosomal dominant polycystic kidney disease (ADPKD). Although the safety profile of...
Via
Benzinga
Sanofi, GSK Start Final Testing Phase Of COVID-19 Vaccine
May 27, 2021
Sanofi SA and GlaxoSmithKline plc have launched a Phase 3 trial for its recombinant COVID-19 vaccine candidate, which they hope to get approved by the end of 2021.
Via
Talk Markets
Exposures
COVID-19
Sanofi, GSK Start Final Testing Phase Of COVID-19 Vaccine
May 27, 2021
Sanofi SA (NASDAQ: SNY) and GlaxoSmithKline plc (NYSE: GSK) have launched a Phase 3 trial for its recombinant COVID-19 vaccine candidate, which they hope...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
May 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...
Via
Benzinga
Exposures
COVID-19
Sanofi, Walvax COVID-19 Vaccine Phase 3 Trials to Commence in Mexico: Reuters
May 25, 2021
Mexico Foreign Minister Marcel Ebrard said that the country would begin phase 3 trials for COVID-19 vaccines by Sanofi SA (NASDAQ: SNY) and China's Walvax...
Via
Benzinga
Exposures
COVID-19
Regeneron-Sanofi's Libtayo Scores CHMP's Positive Opinion For Two Advanced Cancer Settings
May 24, 2021
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions for Regeneron Pharmaceuticals Inc (...
Via
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.